Merck asks FDA for emergency approval of its antiviral COVID-19 pill
Posted on AllSides October 11th, 2021
From The Right
Pharmaceutical giant Merck and its partner Ridgeback Biotherapeutics announced Monday that it has asked the Food and Drug Administration for emergency approval of its COVID-19 pill after the experimental drug showed “compelling results” in clinical trials.
The pill, called molnupiravir, cut the risk of hospitalization or death in patients with mild to moderate COVID-19 by about 50 percent in a late-stage trial, according to data from a phase three clinical trial shared earlier this month.
“The extraordinary impact of this pandemic demands that we move with unprecedented urgency, and that is what our...